Ron Leuty, of bizjournals.com, details a resurgence of the biotech venture capital industry in the San Francisco area. According to the recent Money Tree report, the bay area collected the most second quarter cash in biotech and medical device areas. Overall, the biotech venture capital is seeing a 26% jump in dollar volume from a year ago. This booming Q2 is only feeding off of a positive Q1, and enticing venture capitalist’s (VC) to invest in these high growth industries. As Greg Vlahos of PricewaterhouseCoopers said in the report, “seeing VC’s investing in promising biotech sectors shows the continued strength of this industry.” Do you think that biotech venture capital will continue to grow at this rate? Read the full article here.
